Sun Pharma Advanced Research Co (NSE:SPARC) Interest Expense: ₹-341 Mil (TTM As of Mar. 2026)


NSE:SPARC Sun Pharma Advanced Research Co Ltd NSE:SPARC
67 GF Score
Price ₹261.71
GF Value ₹4,511.92
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Sun Pharma Advanced Research Co Interest Expense?

Sun Pharma Advanced Research Co NSE:SPARC +9.33% 67 Interest Expense is ₹-341 Mil as of Mar. 2026. GuruFocus rates NSE:SPARC with a GF Score™ of 67/100 and a GF Value™ of ₹4,511.92 (Possible Value Trap). The stock has 7 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Sun Pharma Advanced Research Co's interest expense for the three months ended in Mar. 2026 was ₹ -116 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-341 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Sun Pharma Advanced Research Co's Operating Income for the three months ended in Mar. 2026 was ₹ 17,708 Mil. Sun Pharma Advanced Research Co's Interest Expense for the three months ended in Mar. 2026 was ₹ -116 Mil. Sun Pharma Advanced Research Co's Interest Coverage for the quarter that ended in Mar. 2026 was 152.13. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Sun Pharma Advanced Research Co  (NSE:SPARC) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Sun Pharma Advanced Research Co's Interest Expense for the three months ended in Mar. 2026 was ₹-116 Mil. Its Operating Income for the three months ended in Mar. 2026 was ₹17,708 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was ₹17 Mil.

Sun Pharma Advanced Research Co's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*17708/-116.4
=152.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Sun Pharma Advanced Research Co Interest Expense Historical Data

* Premium members only.

The historical data trend for Sun Pharma Advanced Research Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sun Pharma Advanced Research Co Interest Expense Chart

Sun Pharma Advanced Research Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -133.29 -76.35 -11.95 -90.40 -341.30

Sun Pharma Advanced Research Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -45.40 -61.90 -75.20 -87.80 -116.40
NSE:SPARC
67GF Score
Sun Pharma Advanced Research Co Ltd NSE:SPARC
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sun Pharma Advanced Research Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-341 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of ₹-341 Mil mean?
Sun Pharma Advanced Research Co (NSE:SPARC) has a Interest Expense of ₹-341 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Sun Pharma Advanced Research Co and its competitors.
Is Sun Pharma Advanced Research Co's Interest Expense too high?
Sun Pharma Advanced Research Co's current Interest Expense is ₹-341 Mil. Overall, Sun Pharma Advanced Research Co has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sun Pharma Advanced Research Co's Interest Expense compare to ZTS and UTHR?
Sun Pharma Advanced Research Co's Interest Expense of ₹-341 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Sun Pharma Advanced Research Co and its competitors. Sun Pharma Advanced Research Co's current Interest Expense is ₹-341 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sun Pharma Advanced Research Co stock overvalued right now?
Based on GuruFocus' analysis, Sun Pharma Advanced Research Co (NSE:SPARC) is currently considered Possible Value Trap. The stock's GF Value™ is ₹4,511.92, compared to a current price of ₹261.71 — trading 94.2% below its estimated fair value. The current Interest Expense is ₹-341 Mil. Sun Pharma Advanced Research Co's overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Sun Pharma Advanced Research Co (NSE:SPARC), the current Interest Expense is ₹-341 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sun Pharma Advanced Research Co (NSE:SPARC) Overvalued in 2026?

Based on GuruFocus' analysis, Sun Pharma Advanced Research Co stock appears to be undervalued. The current stock price of ₹261.71 is trading 94.2% below its estimated GF Value™ of ₹4,511.92. GuruFocus considers Sun Pharma Advanced Research Co to be Possible Value Trap.

Key valuation signals for NSE:SPARC:

  • Interest Expense: ₹-341 Mil
  • GF Value™: ₹4,511.92 vs. price of ₹261.71 (94.2% below fair value)
  • GF Score™: 67/100 with 7 warning signs

No single metric tells the full story. See the NSE:SPARC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sun Pharma Advanced Research Co Business Description

Other Exchanges 532872:India
Address Off Mahakali Caves Road, 17-B, Mahal Industrial Estate, Andheri (East), Mumbai, MH, IND, 400093
Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in other countries.
67GF Score

Get the complete analysis for NSE:SPARC

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹261.71
Price
₹4,511.92
GF Value